These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 19433358

  • 41. Sulfonamides with the N-alkyl-N'-dialkylguanidine moiety as 5-HT7 receptor ligands.
    Zajdel P, Subra G, Verdie P, Gabzdyl E, Bojarski AJ, Duszyńska B, Martinez J, Pawłowski M.
    Bioorg Med Chem Lett; 2009 Aug 15; 19(16):4827-31. PubMed ID: 19560916
    [Abstract] [Full Text] [Related]

  • 42. (Phenylpiperazinyl-butyl)oxindoles as selective 5-HT7 receptor antagonists.
    Volk B, Barkóczy J, Hegedus E, Udvari S, Gacsályi I, Mezei T, Pallagi K, Kompagne H, Lévay G, Egyed A, Hársing LG, Spedding M, Simig G.
    J Med Chem; 2008 Apr 24; 51(8):2522-32. PubMed ID: 18361484
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. (1-Butyl-4-piperidinyl)methyl 8-amino-7-chloro-1,4-benzodioxane-5-carboxylate hydrochloride: a highly potent and selective 5-HT4 receptor antagonist derived from metoclopramide.
    Gaster LM, Jennings AJ, Joiner GF, King FD, Mulholland KR, Rahman SK, Starr S, Wyman PA, Wardle KA, Ellis ES.
    J Med Chem; 1993 Dec 10; 36(25):4121-3. PubMed ID: 8258837
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Identification of a novel series of selective 5-HT7 receptor antagonists.
    Forbes IT, Cooper DG, Dodds EK, Douglas SE, Gribble AD, Ife RJ, Lightfoot AP, Meeson M, Campbell LP, Coleman T, Riley GJ, Thomas DR.
    Bioorg Med Chem Lett; 2003 Mar 24; 13(6):1055-8. PubMed ID: 12643910
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status.
    Ferrero H, Solas M, Francis PT, Ramirez MJ.
    CNS Drugs; 2017 Jan 24; 31(1):19-32. PubMed ID: 27914038
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Aminopiperidine indazoles as orally efficacious melanin concentrating hormone receptor-1 antagonists.
    Vasudevan A, Souers AJ, Freeman JC, Verzal MK, Gao J, Mulhern MM, Wodka D, Lynch JK, Engstrom KM, Wagaw SH, Brodjian S, Dayton B, Falls DH, Bush E, Brune M, Shapiro RD, Marsh KC, Hernandez LE, Collins CA, Kym PR.
    Bioorg Med Chem Lett; 2005 Dec 01; 15(23):5293-7. PubMed ID: 16203136
    [Abstract] [Full Text] [Related]

  • 53. New serotonin 5-HT(6) ligands from common feature pharmacophore hypotheses.
    Kim HJ, Doddareddy MR, Choo H, Cho YS, No KT, Park WK, Pae AN.
    J Chem Inf Model; 2008 Jan 01; 48(1):197-206. PubMed ID: 18044950
    [Abstract] [Full Text] [Related]

  • 54. Therapeutic Potential of 5-HT6 Receptor Agonists.
    Karila D, Freret T, Bouet V, Boulouard M, Dallemagne P, Rochais C.
    J Med Chem; 2015 Oct 22; 58(20):7901-12. PubMed ID: 26099069
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. A new serotonin 5-HT6 receptor antagonist with procognitive activity - Importance of a halogen bond interaction to stabilize the binding.
    González-Vera JA, Medina RA, Martín-Fontecha M, Gonzalez A, de la Fuente T, Vázquez-Villa H, García-Cárceles J, Botta J, McCormick PJ, Benhamú B, Pardo L, López-Rodríguez ML.
    Sci Rep; 2017 Jan 24; 7():41293. PubMed ID: 28117458
    [Abstract] [Full Text] [Related]

  • 57. Serotonergic 5-HT6 Receptor Antagonists: Heterocyclic Chemistry and Potential Therapeutic Significance.
    Bali A, Singh S.
    Curr Top Med Chem; 2015 Jan 24; 15(17):1643-62. PubMed ID: 25915615
    [Abstract] [Full Text] [Related]

  • 58. Novel aminoethylbiphenyls as 5-HT7 receptor ligands.
    Paillet-Loilier M, Fabis F, Lepailleur A, Bureau R, Butt-Gueulle S, Dauphin F, Lesnard A, Delarue C, Vaudry H, Rault S.
    Bioorg Med Chem Lett; 2007 Jun 01; 17(11):3018-22. PubMed ID: 17419056
    [Abstract] [Full Text] [Related]

  • 59. 5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia.
    de Bruin NM, Kruse CG.
    Curr Pharm Des; 2015 Jun 01; 21(26):3739-59. PubMed ID: 26044973
    [Abstract] [Full Text] [Related]

  • 60. The discovery and SAR of indoline-3-carboxamides--a new series of 5-HT6 antagonists.
    Reid M, Carlyle I, Caulfield WL, Clarkson TR, Cusick F, Epemolu O, Gilfillan R, Goodwin R, Jaap D, O'Donnell EC, Presland J, Rankovic Z, Spinks D, Spinks G, Thomson AM, Thomson F, Strain J, Wishart G.
    Bioorg Med Chem Lett; 2010 Jun 15; 20(12):3713-6. PubMed ID: 20471831
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.